1. "Master of Science in Clinical and Translational Cancer Research "
Formats
  1. Meeting Abstract (520)
  2. Journal Article (329)
  3. Review (40)
  4. Miscellaneous (16)
  5. Research Letter (15)
  6. Editorial (14)
  7. Correspondence (12)
  8. Conference Paper (4)
  9. Book Section (3)
  10. Guidelines (3)
Groups
  1. CTCR Scholars (956)
  2. MSK Grad Students (956)
  3. Master of Science in Clinical and Translational Cancer Research (956)
  4. Department of Medicine (854)
  5. Hematologic Malignancies, Division of (652)
  6. Center for Hematologic Malignancies (631)

More Groups

People
  1. Sergio Giralt (379)
  2. Miguel-Angel Perales (357)
  3. Parastoo Dahi (294)
  4. Sean Devlin (265)
  5. Doris Ponce (254)
  6. Roni Tamari (209)

More People

Years
  1. 2025 (42)
  2. 2024 (109)
  3. 2023 (140)
  4. 2022 (121)
  5. 2021 (104)
  6. 2020 (119)

More Years

Publications
  1. Blood (191)
  2. Biology of Blood and Marrow Transplantation (153)
  3. Journal of Clinical Oncology (79)
  4. Annals of Surgical Oncology (78)
  5. Bone Marrow Transplantation (55)
  6. Transplantation and Cellular Therapy (42)

More Publications

Publishers
  1. American Society of Hematology (223)
  2. Elsevier Inc. (219)
  3. Springer (90)
  4. American Society of Clinical Oncology (87)
  5. Nature Publishing Group (82)
  6. American Association for Cancer Research (29)

More Publishers

Results (956)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT
    Journal Article

    Andrlová, H.; Miltiadous, O.; Kousa, A. I.; Dai, A.; DeWolf, S.; Violante, S.; Park, H. Y.; Janaki-Raman, S.; Gardner, R.; El Daker, S.; more...
    Science Translational Medicine (2022)

    Fulltext@MSK | Save
  • In-transit melanoma: A multi-institutional analysis of outcomes
    Meeting Abstract

    Bello, D.; Rhodin, K. E.; Brady, M. S.; Bartlett, E.; Mosca, P.; Salama, A. K.; Tyler, D.; Ariyan, C.; Beasley, G.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Hepatic arterial infusion pump chemotherapy for management of unresectable colorectal liver metastases with extrahepatic disease
    Meeting Abstract

    Saadat, L. V.; Goldman, D. A.; Gonen, M.; Soares, K. C.; Balachandran, V. P.; Wei, A. C.; Kingham, T. P.; Jarnagin, W. R.; Drebin, J.; Connell, L. C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Sentinel lymph node biopsy in patients with t1a cutaneous malignant melanoma
    Meeting Abstract

    Shannon, A. B.; Carr, M.; Bogatch, K.; Thaler, A. S.; Kelly, N. J.; Fowler, G.; Straker, R. J.; Sondak, V.; Miura, J. T.; Faries, M. B.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Stage migration as a consequence of omitting completion lymph node dissection for melanoma
    Meeting Abstract

    Senders, Z. J.; Bartlett, E.; Mouw, T. J.; McMasters, K. M.; Egger, M. E.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Recurrence-free survival versus overall survival as a primary end point for resectable colorectal liver metastasis studies: Analysis of 2,983 curative-intent hepatectomies
    Meeting Abstract

    Ecker, B.; Lee, J.; Saadat, L. V.; Balachandran, V. P.; Drebin, J.; Jarnagin, W. R.; Kemeny, N. E.; Kingham, T. P.; Saltz, L.; Soares, K. C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Preoperative management of perihilar cholangiocarcinoma
    Review

    Ellis, R. J.; Soares, K. C.; Jarnagin, W. R.
    Cancers (2022)

    Fulltext@MSK | Save
  • Neoadjuvant and adjuvant antitumor vaccination alone or combination with PD1 blockade and CD137 agonism in patients with resectable pancreatic adenocarcinoma
    Meeting Abstract

    Heumann, T. R.; Judkins, C.; Lim, S. J.; Wang, H.; Parkinson, R.; Gai, J.; Celiker, B.; Durham, J. N.; Laheru, D. A.; De Jesus-Acosta, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: A single-center experience
    Journal Article

    Pak, T. K.; Dixon, B. N.; Buege, M. J.; Dao, P. H.; Leary, M. H.; Jarrett, J. C.; Duggan, T. A.; Caron, P.; Falchi, L.; Hamlin, P.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma
    Journal Article

    Halwani, A. S.; Panizo, C.; Isufi, I.; Herrera, A. F.; Okada, C. Y.; Cull, E. H.; Kis, B.; Chaves, J. M.; Bartlett, N. L.; Ai, W.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save